X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7061) 7061
Publication (807) 807
Newsletter (280) 280
Book Review (231) 231
Newspaper Article (188) 188
Book Chapter (131) 131
Book / eBook (116) 116
Conference Proceeding (37) 37
Government Document (30) 30
Report (20) 20
Magazine Article (16) 16
Transcript (10) 10
Dissertation (9) 9
Trade Publication Article (6) 6
Reference (3) 3
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4322) 4322
index medicus (3574) 3574
vaccines (3451) 3451
animals (3350) 3350
immunology (2882) 2882
female (1978) 1978
vaccination (1725) 1725
vaccine (1460) 1460
mice (1397) 1397
male (1388) 1388
vaccines, synthetic - immunology (1350) 1350
antigens (1329) 1329
immunization (1256) 1256
immunotherapy (1252) 1252
medicine, research & experimental (1248) 1248
proteins (1048) 1048
health aspects (975) 975
adult (945) 945
immunogenicity (925) 925
immune response (857) 857
research (856) 856
dendritic cells (842) 842
cancer (840) 840
vaccines, synthetic - adverse effects (819) 819
infectious diseases (776) 776
vaccines, synthetic - administration & dosage (734) 734
antibodies (676) 676
medical research (674) 674
infections (667) 667
middle aged (667) 667
infection (642) 642
immune-responses (639) 639
clinical trials (631) 631
viruses (629) 629
peptides (593) 593
pharmacology & pharmacy (588) 588
analysis (586) 586
allergy and immunology (579) 579
immune system (575) 575
medicine (561) 561
t cells (556) 556
safety (547) 547
oncology (543) 543
immunity (536) 536
care and treatment (535) 535
mice, inbred balb c (532) 532
microbiology (530) 530
prevention (525) 525
biotechnology & applied microbiology (516) 516
article (478) 478
veterinary sciences (474) 474
adjuvants, immunologic - administration & dosage (459) 459
adolescent (456) 456
adjuvant (452) 452
lymphocytes (441) 441
virology (438) 438
clinical trials as topic (434) 434
cancer vaccines - immunology (424) 424
influenza (418) 418
enzyme-linked immunosorbent assay (417) 417
adjuvants (416) 416
studies (416) 416
cancer vaccines (413) 413
vaccines, synthetic - genetics (404) 404
review (401) 401
research article (394) 394
antigen (393) 393
cancer vaccines - therapeutic use (388) 388
medicine, experimental (379) 379
immune-response (374) 374
viral vaccines - immunology (371) 371
multidisciplinary sciences (370) 370
treatment outcome (351) 351
disease models, animal (347) 347
dna (344) 344
immunotherapy - methods (343) 343
vaccines - immunology (339) 339
tumors (334) 334
t-lymphocytes - immunology (332) 332
antibodies, viral - blood (326) 326
deoxyribonucleic acid--dna (323) 323
t-cell responses (321) 321
lymphocytes t (319) 319
aged (318) 318
efficacy (318) 318
cytokines (311) 311
virus diseases (309) 309
science (305) 305
responses (303) 303
disease (302) 302
in-vivo (301) 301
malaria (299) 299
expression (298) 298
genetic vectors (297) 297
public health (296) 296
vaccination - methods (296) 296
t-cells (294) 294
drug delivery systems (292) 292
vaccines, dna - immunology (289) 289
protection (287) 287
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (80) 80
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
Online Resources - Online (7) 7
UofT at Mississauga - Stacks (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Robarts - Stacks (4) 4
UofT at Scarborough - Stacks (4) 4
Baycrest Hospital - Resident/Client Library (2) 2
Engineering & Comp. Sci. - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Mt Sinai Hospital - Online (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
University College (Laidlaw) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7750) 7750
Russian (35) 35
Spanish (20) 20
Chinese (10) 10
French (8) 8
German (8) 8
Italian (6) 6
Polish (4) 4
Japanese (2) 2
Portuguese (2) 2
Croatian (1) 1
Dutch (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 10, pp. 1156 - 1166
Summary Background Safe and effective vaccines against Ebola could prevent or control outbreaks. The safe use of replication-competent vaccines requires a... 
Infectious Disease | INFECTIOUS DISEASES | MARBURG VIRUS | ACTIVATION | DUCK RUBELLA VACCINE | IMMUNE-RESPONSES | PROTECTS NONHUMAN-PRIMATES | VESICULAR STOMATITIS | GLYCOPROTEINS | INFECTION | FEVER | AGE | Hemorrhagic Fever, Ebola - prevention & control | Vasculitis - epidemiology | Arthritis - epidemiology | Humans | Middle Aged | Vasculitis - pathology | Antigens, Viral - genetics | Male | Vaccination - adverse effects | Vaccines, Synthetic - immunology | Ebolavirus - genetics | Antibodies, Viral - blood | Dermatitis - epidemiology | Drug Carriers | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Arthritis - chemically induced | Vaccination - methods | Vaccines, Synthetic - adverse effects | Vesiculovirus - genetics | Adult | Ebola Vaccines - immunology | Female | Vasculitis - chemically induced | Placebos - administration & dosage | Double-Blind Method | Arthritis - pathology | Ebola Vaccines - administration & dosage | Ebola Vaccines - adverse effects | Switzerland | Drug-Related Side Effects and Adverse Reactions - epidemiology | Dermatitis - pathology | Adolescent | Aged | Vaccines, Synthetic - administration & dosage | Ebola virus | Hospitals | Clinical trials | Product development | Cross infection | Vaccines | Nosocomial infections | Health aspects | Epidemics | Disease | Arthritis | Dermatitis | Ankle | Wrist | Consortia | Pain | Adenoviruses | Fingers & toes | Skin | Public health
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 11/2016, Volume 120, pp. 1 - 14
Vaccines have been the single most significant advancement in public health, preventing morbidity and mortality in millions of people annually. Vaccine... 
Nanoparticles | Vaccine | SAPN | Adjuvant | Rationally designed | GOLD NANOPARTICLES | HEPATITIS-B-VACCINE | ESCHERICHIA-COLI | NANOPARTICLE VACCINES | MONOPHOSPHORYL-LIPID-A | TOLL-LIKE RECEPTOR-5 | T-CELL RESPONSES | IMMUNE-RESPONSES | VIRUS-LIKE PARTICLES | PHARMACOLOGY & PHARMACY | ANTIGEN-CONTAINING LIPOSOMES | Recombinant Proteins - therapeutic use | Veterinary Drugs - adverse effects | History, 21st Century | Nanoparticles - chemistry | Humans | Vaccines, Synthetic - immunology | Antigens - therapeutic use | Vaccines - chemistry | Allergy and Immunology - history | Nanoparticles - therapeutic use | Vaccines, Subunit - adverse effects | Biopharmaceutics - history | Adjuvants, Immunologic - therapeutic use | Communicable Diseases - veterinary | Chemistry, Pharmaceutical - trends | Vaccines, Synthetic - chemistry | History, 20th Century | Recombinant Proteins - chemistry | Veterinary Drugs - immunology | Protein Engineering - trends | Antigens - chemistry | Communicable Disease Control - trends | Biopharmaceutics - methods | Drug Delivery Systems - trends | Protein Engineering - veterinary | Drug Delivery Systems - adverse effects | Veterinary Drugs - chemistry | Veterinary Drugs - therapeutic use | Drug Delivery Systems - veterinary | Nanoparticles - adverse effects | Recombinant Proteins - adverse effects | Vaccines - therapeutic use | Adjuvants, Immunologic - adverse effects | Antigens - adverse effects | Vaccines, Subunit - therapeutic use | Vaccines, Synthetic - adverse effects | Adjuvants, Immunologic - chemistry | Allergy and Immunology - trends | Drug Design | Chemistry, Pharmaceutical - history | Communicable Disease Control - history | Vaccines, Subunit - chemistry | Biopharmaceutics - trends | Vaccines - immunology | Vaccines, Synthetic - therapeutic use | Vaccines, Subunit - immunology | Protein Folding | Vaccines - adverse effects | Animals | Recombinant Proteins - immunology | Communicable Diseases - immunology | Antigens - immunology | History, 19th Century | Vaccines | Rationally Designed
Journal Article
Vaccine, ISSN 0264-410X, 2011, Volume 29, Issue 42, pp. 7229 - 7241
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 34, Issue 3, pp. 313 - 319
Highlights • CMV seronegative girls between 12 and 17 years of age received CMV glycoprotein B (gB) vaccine with MF59 or saline placebo at 0, 1 and 6 months. •... 
Allergy and Immunology | Cytomegalovirus | Vaccine | CMV gB | Adolescent | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNITY | PREVENTION | TRANSPLANT RECIPIENTS | IMMUNOLOGY | ADJUVANT | PLASMA | DNA | DISEASE | CMV INFECTION | Cytomegalovirus Vaccines - adverse effects | Adjuvants, Immunologic - administration & dosage | Vaccines, Subunit - genetics | Humans | DNA, Viral - analysis | Cytomegalovirus Infections - immunology | Vaccines, Synthetic - immunology | Cytomegalovirus Vaccines - administration & dosage | Antibodies, Viral - blood | Drug-Related Side Effects and Adverse Reactions - pathology | Adjuvants, Immunologic - adverse effects | Cytomegalovirus Infections - prevention & control | Vaccines, Synthetic - adverse effects | Blood - virology | Polymerase Chain Reaction | Polysorbates - administration & dosage | Female | Immunization Schedule | Vaccines, Subunit - adverse effects | Child | Cytomegalovirus Vaccines - genetics | Placebos - administration & dosage | Antigens, Viral - analysis | Polysorbates - adverse effects | Viral Envelope Proteins - genetics | Double-Blind Method | Vaccines, Synthetic - genetics | Squalene - administration & dosage | Urine - virology | Vaccines, Subunit - immunology | Squalene - adverse effects | Drug-Related Side Effects and Adverse Reactions - epidemiology | Vaccines, Subunit - administration & dosage | Viral Envelope Proteins - immunology | Vaccines, Synthetic - administration & dosage | DNA, Viral - genetics | Cytomegalovirus Vaccines - immunology | Clinical trials | Medical colleges | Vaccines | Teenage girls | Antigens | Cytomegalovirus infections | Vaccination | Urine | Confidence intervals | Substance abuse treatment | Consent | Hispanic Americans | Population | Infections | adolescent | vaccine | cytomegalovirus
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 31, Issue 3, pp. 524 - 532
Highlights ► This Phase 1 trial evaluated the safety and immunogenicity of an RSV (F) nanoparticle vaccine. ► The vaccine was well-tolerated and no related... 
Allergy and Immunology | Respiratory syncytial virus (RSV) | Palivizumab | Fusion protein (F protein) | Competitive ELISA | SF9 insect cell | Microneutralization | Aluminum phosphate | Anti-F IgG | Nanoparticle vaccine | UNITED-STATES | MEDICINE, RESEARCH & EXPERIMENTAL | NEUTRALIZING ANTIBODIES | IMMUNE GLOBULIN | COTTON RATS | INFLUENZA | RISK | IMMUNOLOGY | F-GLYCOPROTEIN | INFANTS | INFECTION | YOUNG-CHILDREN | Recombinant Fusion Proteins - immunology | Single-Blind Method | Biotechnology | Respiratory Syncytial Virus Vaccines - immunology | Adjuvants, Immunologic - administration & dosage | Aluminum Compounds - adverse effects | Phosphates - administration & dosage | Recombinant Fusion Proteins - adverse effects | Humans | Middle Aged | Male | Nanoparticles - adverse effects | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Adjuvants, Immunologic - adverse effects | Young Adult | Respiratory Syncytial Virus Vaccines - adverse effects | Sf9 Cells | Technology, Pharmaceutical | Vaccines, Virosome - immunology | Vaccines, Synthetic - adverse effects | Placebos - adverse effects | Adult | Female | Placebos - administration & dosage | Recombinant Fusion Proteins - administration & dosage | Vaccines, Virosome - administration & dosage | Vaccines, Synthetic - genetics | Vaccines, Virosome - genetics | Animals | Aluminum Compounds - administration & dosage | Phosphates - adverse effects | Vaccines, Virosome - adverse effects | Respiratory Syncytial Virus Vaccines - administration & dosage | Adolescent | Recombinant Fusion Proteins - genetics | Nanoparticles - administration & dosage | Vaccines, Synthetic - administration & dosage | Respiratory Syncytial Virus Vaccines - genetics | Antibodies, Neutralizing - blood | Virus diseases | Phosphates | Vaccines | Immunoglobulin G | Enzyme-linked immunosorbent assay | Proteins | Nanoparticles | Infections | Index Medicus
Journal Article
PLoS Medicine, ISSN 1549-1277, 11/2016, Volume 13, Issue 11, p. e1002181
Journal Article
by Agnandji, Selidji Todagbe and Lell, Bertrand and Fernandes, José Francisco and Abossolo, Béatrice Peggy and Methogo, Barbara Gaelle Nfono Ondo and Kabwende, Anita Lumeka and Adegnika, Ayola Akim and Mordmüller, Benjamin and Issifou, Saadou and Kremsner, Peter Gottfried and Sacarlal, Jahit and Aide, Pedro and Lanaspa, Miguel and Aponte, John J and Machevo, Sonia and Acacio, Sozinho and Bulo, Helder and Sigauque, Betuel and Macete, Eusébio and Alonso, Pedro and Abdulla, Salim and Salim, Nahya and Minja, Rose and Mpina, Maxmillian and Ahmed, Saumu and Ali, Ali Mohammed and Mtoro, Ali Takadir and Hamad, Ali Said and Mutani, Paul and Tanner, Marcel and Tinto, Halidou and D'Alessandro, Umberto and Sorgho, Hermann and Valea, Innocent and Bihoun, Biébo and Guiraud, Issa and Kaboré, Berenger and Sombié, Olivier and Guiguemdé, Robert Tinga and Ouédraogo, Jean Bosco and Hamel, Mary J and Kariuki, Simon and Oneko, Martina and Odero, Chris and Otieno, Kephas and Awino, Norbert and McMorrow, Meredith and Muturi-Kioi, Vincent and Laserson, Kayla F and Slutsker, Laurence and Otieno, Walter and Otieno, Lucas and Otsyula, Nekoye and Gondi, Stacey and Otieno, Allan and Owira, Victorine and Oguk, Esther and Odongo, George and Ben Woods, Jon and Ogutu, Bernhards and Njuguna, Patricia and Chilengi, Roma and Akoo, Pauline and Kerubo, Christine and Maingi, Charity and Lang, Trudie and Olotu, Ally and Bejon, Philip and Marsh, Kevin and Mwambingu, Gabriel and Owusu-Agyei, Seth and Asante, Kwaku Poku and Osei-Kwakye, Kingsley and Boahen, Owusu and Dosoo, David and Asante, Isaac and Adjei, George and Kwara, Evans and Chandramohan, Daniel and Greenwood, Brian and Lusingu, John and Gesase, Samwel and Malabeja, Anangisye and Abdul, Omari and Mahende, Coline and Liheluka, Edwin and Malle, Lincoln and Lemnge, Martha and Theander, Thor G and Drakeley, Chris and Ansong, Daniel and Agbenyega, Tsiri and Adjei, Samuel and Boateng, Harry Owusu and Rettig, Theresa and Bawa, John and Sylverken, Justice and Sambian, David and Sarfo, Anima and Agyekum, Alex and ... and The RTS,S Clinical Trials Partnership and RTS S Clin Trials Partnership and RTS,S Clinical Trials Partnership
The New England Journal of Medicine, ISSN 0028-4793, 12/2012, Volume 367, Issue 24, pp. 2284 - 2295
Journal Article
JAMA, ISSN 0098-7484, 04/2016, Volume 315, Issue 15, pp. 1610 - 1623
Journal Article